New NIH Bioinformatics Center

Recognizing the growing importance of computational and information sciences to biology, the National Institutes of Health is establishing a new Center for Bioinformatics and Computational Biology (CBCB). The new center is designed to support research and training in areas that merge biology with computer sciences, engineering, mathematics, and physics. "The future of the biological sciences will be driven by advances in bioinformatics and computational biology," says Marvin Cassman, director o

Written byTed Agres
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

"The future of the biological sciences will be driven by advances in bioinformatics and computational biology," says Marvin Cassman, director of the National Institute of General Medical Sciences (NIGMS). The new center, to be located with the NIGMS, will handle this institute's projects.

While the new center will primarily focus on developing and coordinating bioinformatics programs within NIGMS, "There's a lot going on that has strong computational elements" throughout NIH, Cassman says. "A large number of these [research activities] will stay where they are within the divisions--cell biology and biophysics, genetics and developmental biology, and so on. But we want to be sure that there's an awareness of the connections between all of these," he explains.

Toward this end, the new center will coordinate the Biomedical Information Science and Technology Initiative Consortium (BISTIC), a committee comprised of senior representatives from each of the NIH institutes and centers as well as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies